DENTSPLY SIRONA Inc.(XRAY)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
XRAY is scheduled to report on Nov 5, 2026, before the market opens. Analysts expect EPS of $0.32.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±9.3%).
Did the stock rise after good news?
The next-day move after each of its last 5 EPS beats and 3 misses.
In plain words: it beat expectations 5 times, but the stock still fell 4 of those 5 times.
- Aug '26Beat▼ -8.0%
- Feb '26Missed▲ +15.5%
- Nov '25Missed▼ -12.7%
- Aug '25Beat▼ -3.3%
- May '25Beat▲ +16.3%
- Feb '25Missed▼ -8.8%
- Nov '24Beat▼ -28.0%
- Nov '23Beat▼ -7.5%
Clear beats and misses with a known reaction only. What counts as a beat
Why did XRAY fall after beating earnings?
5 of XRAY's last 8 reactions went against the EPS result. What stands out in each:
XRAY beat EPS estimates in 5 quarters, and the stock still closed lower the next day 4 times. In 1 of the 4 where we have price data, the stock had already run up before the report.
- Aug 6, 2026EPS beat +48.6%stock -8.0% next day
- It had risen 10.8% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 1.4% higher, but sellers took over and it closed -8.0%.
- Aug 7, 2025EPS beat +4.0%stock -3.3% next day
- It opened 4.4% higher, but sellers took over and it closed -3.3%.
- Nov 7, 2024EPS beat +4.2%stock -28.0% next day
- It opened 19.9% lower as soon as trading resumed.
- Nov 2, 2023EPS beat +2.1%stock -7.5% next day
- It opened 12.5% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 3)
- Feb 26, 2026EPS missed -6.9%stock +15.5% next day
- It opened 2.7% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was XRAY's earnings move already priced in?
XRAY's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does XRAY hold its opening gap after earnings?
XRAY's opening move after each report and where it closed that day.
In 10 reports XRAY opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 10 times (40%), and fully reversed 4 times. Gaps up faded 3 of 5; gaps down recovered 1 of 5.
- Aug 6, 2026ReversedOpened +1.4%, closed -8.0%
- Feb 26, 2026HeldOpened +2.7%, closed +15.5%
- Nov 6, 2025HeldOpened -10.0%, closed -12.7%
- Aug 7, 2025ReversedOpened +4.4%, closed -3.3%
- May 8, 2025HeldOpened +8.0%, closed +16.3%
- Nov 7, 2024HeldOpened -19.9%, closed -28.0%
- Jul 31, 2024ReversedOpened -1.2%, closed +1.3%
- May 2, 2024HeldOpened -2.0%, closed -6.0%
What the history says
- It fell after 4 of its 5 EPS beats (80%): beating estimates has not been enough on its own.
XRAY earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | After close | $0.35 | $0.52 | +48.6% | -7.97% | -11.85% |
| May 5, 2026 | After close | $0.27 | $0.27 | 0.0% | -2.02% | -3.25% |
| Feb 26, 2026 | After close | $0.29 | $0.27 | -6.9% | +15.50% | +4.64% |
| Nov 6, 2025 | Before open | $0.45 | $0.37 | -17.8% | -12.68% | -12.84% |
| Aug 7, 2025 | Before open | $0.50 | $0.52 | +4.0% | -3.29% | -8.41% |
| May 8, 2025 | Before open | $0.30 | $0.43 | +43.3% | +16.30% | +22.44% |
| Feb 27, 2025 | Before open | $0.43 | $0.26 | -39.5% | -8.83% | -14.99% |
| Nov 7, 2024 | Before open | $0.48 | $0.50 | +4.2% | -28.02% | -26.40% |
| Jul 31, 2024 | Before open | $0.49 | $0.49 | 0.0% | +1.34% | -4.82% |
| May 2, 2024 | Before open | $0.42 | $0.42 | 0.0% | -5.96% | -6.40% |
| Feb 29, 2024 | Before open | $0.44 | $0.44 | 0.0% | -1.86% | -0.06% |
| Nov 2, 2023 | Before open | $0.48 | $0.49 | +2.1% | -7.46% | -7.39% |
Consensus for the next report: EPS $0.32, revenue $880.02M.
XRAY Earnings FAQ
Answers computed from DENTSPLY SIRONA Inc.'s reported history
XRAY is scheduled to report on Nov 5, 2026, before the market opens. Analysts expect EPS of $0.32.
Over the last 12 quarters with a usable EPS surprise, XRAY beat the consensus estimate 5 times (42%), missed 3 and landed in line 4.
Across its last 12 quarters with a measured reaction, XRAY moved an average of ±9.3% in the first session after reporting. It closed higher 25% of the time; the largest gain was 16.3% and the largest drop -28.0%.
XRAY fell in the first session after 4 of its last 5 EPS beats (80%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 1 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, XRAY moved an average of -0.8% in the 20 trading sessions before reporting and was higher in 42% of them. After a run-up of 3% or more (4 quarters), it fell the next day 25% of the time, averaging +6.3%. After a drop of 3% or more (5 quarters), it rose the next day 0% of the time, averaging -5.5%. This describes past reports; it is not a forecast.
In 10 reports XRAY opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 10 times (40%), and fully reversed 4 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · XRAY: 12 reported quarters, latest Aug 6, 2026. Information only, not investment advice.
Looking for more on XRAY?
Price charts, forecast, fundamentals and risk pages for XRAY are not on Tickzen yet. You can run a full stock analysis now.
Run the XRAY Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun